Advertisement
Advertisement
U.S. markets close in 27 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Genmab A/S (GMAB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
32.37+0.06 (+0.19%)
As of 03:33PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close32.31
Open32.29
Bid32.44 x 1100
Ask32.46 x 1800
Day's Range32.07 - 32.64
52 Week Range26.19 - 49.07
Volume325,677
Avg. Volume689,208
Market Cap21.207B
Beta (5Y Monthly)0.71
PE Ratio (TTM)63.73
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
5% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for GMAB

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Genmab A/S
    Daily – Vickers Top Buyers & Sellers for 06/23/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • GlobeNewswire

    Transactions in connection with share buy-back program

    Company Announcement COPENHAGEN, Denmark; June 27, 2022 – Genmab A/S (Nasdaq: GMAB). On June 17, 2022 Genmab announced the initiation of a share buy-back program to mitigate dilution from warrant exercises and to honor our commitments under our Restricted Stock Units program. The share buy-back program is expected to be completed no later than August 31, 2022 and comprises up to 370,000 shares. The following transactions were executed under the program from June 20, 2022 to June 24, 2022: No. of

  • GlobeNewswire

    Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

    Company Announcement COPENHAGEN, Denmark; June 23, 2022 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) made by managerial employees and their closely associated persons. The company’s managerial employees and their closely associated persons have given Genmab A/S power of attorney on their behalf to publish trading in

  • GlobeNewswire

    Major Shareholder Announcement

    Company Announcement Major shareholder announcement for Genmab A/S COPENHAGEN, Denmark; June 20, 2022 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Wellington Management Group LLP has informed us that, as of June 15, 2022 Wellington Management Group LLP had decreased their holding of shares in Genmab A/S to 4.99% of the share capital and voting rights in Genmab A/S, so that through shares and financial instruments they held the voting

Advertisement
Advertisement